PEBO Q2 Deep Dive: Loan Growth Offsets Credit Pressures, Margin Outlook StableRegional banking company Peoples Bancorp (
NASDAQ:PEBO) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3.2% year on year to $115 million. Its non-GAAP profit of $0.61 per share was 21.5% below analysts’ consensus estimates.
RTX Q2 Deep Dive: Strong Demand and Bookings Offset by Margin Pressures and TariffsAerospace and defense company Raytheon (
NYSE:RTX) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 9% year on year to $21.58 billion. The company’s full-year revenue guidance of $85.13 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $1.56 per share was 9.1% above analysts’ consensus estimates.
NOC Q2 Deep Dive: Defense Demand, International Growth, and Key Program Progress Drive ResultsSecurity and aerospace company Northrop Grumman (
NYSE:NOC) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 1.3% year on year to $10.35 billion. The company expects the full year’s revenue to be around $42.15 billion, close to analysts’ estimates. Its non-GAAP profit of $6.94 per share was 1.5% above analysts’ consensus estimates.
DGX Q2 Deep Dive: Acquisitions, Advanced Diagnostics, and Utilization Trends Drive GrowthHealthcare diagnostics company Quest Diagnostics (
NYSE:DGX) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 15.2% year on year to $2.76 billion. The company’s full-year revenue guidance of $10.86 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $2.64 per share was 2.5% above analysts’ consensus estimates.
VMI Q2 Deep Dive: Realignment Costs, Margin Pressure, and Utility Backlog Shape OutlookInfrastructure and agriculture equipment manufacturer Valmont Industries (
NYSE:VMI) announced better-than-expected revenue in Q2 CY2025, with sales up 1% year on year to $1.05 billion. The company expects the full year’s revenue to be around $4.1 billion, close to analysts’ estimates. Its non-GAAP profit of $4.88 per share was 2.1% above analysts’ consensus estimates.
KO Q2 Deep Dive: Volume Declines Offset by Pricing and Margin Gains Amid Dynamic EnvironmentBeverage company Coca-Cola (
NYSE:KO) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 2.1% year on year to $12.62 billion. Its non-GAAP profit of $0.87 per share was 3.9% above analysts’ consensus estimates.
EFX Q2 Deep Dive: Mixed Outlook as Mortgage Gains Offset by Government and Hiring UncertaintyCredit reporting giant Equifax (
NYSE:EFX) announced better-than-expected revenue in Q2 CY2025, with sales up 7.4% year on year to $1.54 billion. On the other hand, next quarter’s revenue guidance of $1.52 billion was less impressive, coming in 0.9% below analysts’ estimates. Its non-GAAP profit of $2 per share was 4.2% above analysts’ consensus estimates.
SHW Q2 Deep Dive: Market Share Gains Offset by Weak Demand and Margin PressurePaint and coating manufacturer Sherwin-Williams (
NYSE:SHW) met Wall Street’s revenue expectations in Q2 CY2025, but sales were flat year on year at $6.31 billion. On the other hand, next quarter’s revenue guidance of $6.16 billion was less impressive, coming in 2.2% below analysts’ estimates. Its non-GAAP profit of $3.38 per share was 11.2% below analysts’ consensus estimates.
IPG Q2 Deep Dive: Strategic Transformation and Omnicom Deal Shape OutlookGlobal advertising conglomerate Interpublic Group (
NYSE:IPG) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 6.6% year on year to $2.17 billion. Its non-GAAP profit of $0.75 per share was 33.7% above analysts’ consensus estimates.
GM Q2 Deep Dive: Tariffs, EV Scaling, and Margin Pressures Shape OutlookAutomotive manufacturer General Motors (
NYSE:GM) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales fell by 1.8% year on year to $47.12 billion. Its non-GAAP profit of $2.53 per share was 2.1% above analysts’ consensus estimates.
IQV Q2 Deep Dive: AI Initiatives and Pipeline Growth Drive Outperformance Amid Margin PressuresClinical research company IQVIA (
NYSE: IQV) announced better-than-expected revenue in Q2 CY2025, with sales up 5.3% year on year to $4.02 billion. The company’s full-year revenue guidance of $16.2 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $2.81 per share was 1.4% above analysts’ consensus estimates.
LMT Q2 Deep Dive: Charges on Legacy Programs Weigh on Results, Guidance ReconfirmedSecurity and Aerospace company Lockheed Martin (
NYSE:LMT) missed Wall Street’s revenue expectations in Q2 CY2025, with sales flat year on year at $18.16 billion. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $74.25 billion at the midpoint. Its GAAP profit of $1.46 per share was 77.3% below analysts’ consensus estimates.
DHI Q2 Deep Dive: Incentives and Market Discipline Steady Results Amid Affordability ChallengesHomebuilder D.R. Horton (
NYSE:DHI) reported Q2 CY2025 results topping the market’s revenue expectations, but sales fell by 7.4% year on year to $9.23 billion. The company expects the full year’s revenue to be around $33.95 billion, close to analysts’ estimates. Its non-GAAP profit of $3.36 per share was 15.8% above analysts’ consensus estimates.
The 5 Most Interesting Analyst Questions From Banner Bank’s Q2 Earnings CallBanner Bank’s first quarter results met Wall Street’s revenue expectations, with non-GAAP earnings per share exceeding consensus estimates. Management attributed this performance to disciplined core deposit growth, strong net interest margin management, and expense controls. CEO Mark Grescovich highlighted the bank’s “moderate risk profile” and resilience amid market volatility, emphasizing continued organic loan and deposit growth. Chief Credit Officer Jill Rice noted that while delinquent and adversely classified loans rose, credit metrics remained within manageable ranges, thanks to proactive portfolio management and a diverse lending book.
CBU Q2 Deep Dive: Deposit Growth, Branch Expansion, and Margin Trends Shape OutlookRegional banking company Community Financial System (
NYSE:CBU) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 8.4% year on year to $199.3 million. Its non-GAAP profit of $0.99 per share was 2% below analysts’ consensus estimates.
GPC Q2 Deep Dive: Tariffs, Cost Actions, and Cautious Outlook Shape ResultsAuto and industrial parts retailer Genuine Parts (
NYSE:GPC) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 3.4% year on year to $6.16 billion. Its non-GAAP profit of $2.10 per share was 2.1% above analysts’ consensus estimates.
5 Must-Read Analyst Questions From United Airlines’s Q2 Earnings CallUnited Airlines' first quarter results reflected resilience in a challenging travel environment, as management pointed to increased brand loyalty and premium segment strength amid softer overall demand. CEO Scott Kirby highlighted that United achieved its highest first-quarter pretax margins since the pandemic, attributing this to gains in loyal customers and operational improvements. Executive Vice President Andrew Nocella noted the impact of weaker demand in off-peak domestic flights, which was partially offset by continued growth in premium cabins and loyalty revenue.
PM Q2 Deep Dive: Smoke-Free Product Momentum Offsets Combustible HeadwindsTobacco company Philip Morris International (
NYSE:PM) missed Wall Street’s revenue expectations in Q2 CY2025, but sales rose 7.1% year on year to $10.14 billion. Its non-GAAP profit of $1.91 per share was 2.8% above analysts’ consensus estimates.
1 Safe-and-Steady Stock to Own for Decades and 2 Facing ChallengesLow-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
3 Profitable Stocks with Open QuestionsEven if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
2 Unpopular Stocks That Deserve Some Love and 1 That UnderwhelmWall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
3 Cash-Producing Stocks for Long-Term InvestorsBusinesses with strong free cash flow tend to be more adaptable and resilient.
Some of these companies shine bright by using their cash wisely to strengthen their market positions.
1 Unpopular Stock That Should Get More Attention and 2 We AvoidWall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
3 Unprofitable Stocks with Questionable FundamentalsRunning at a loss can be a red flag.
Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.
1 Profitable Stock on Our Buy List and 2 We IgnoreWhile profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
1 Cash-Producing Stock with Competitive Advantages and 2 We Find RiskyA company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
3 of Wall Street’s Favorite Stocks with Impressive FundamentalsWall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
3 Overrated Stocks We Keep Off Our RadarEach stock in this article is trading near its 52-week high.
These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
1 S&P 500 Stock with Impressive Fundamentals and 2 We Brush OffWhile the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
2 Cash-Heavy Stocks with Exciting Potential and 1 We QuestionA surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth.
Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.
3 Low-Volatility Stocks with Open QuestionsA stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
2 Growth Stocks to Add to Your Roster and 1 We Turn DownGrowth boosts valuation multiples, but it doesn’t always last forever.
Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
1 Momentum Stock to Target This Week and 2 We Find RiskyGreat things are happening to the stocks in this article.
They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
3 Healthcare Stocks with Warning SignsPersonal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 13.6%. This performance is a stark contrast from the S&P 500’s 3.1% gain.
3 of Wall Street’s Favorite Stocks with Questionable FundamentalsWall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
3 Small-Cap Stocks We Think Twice AboutMany small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
1 Mid-Cap Stock on Our Buy List and 2 We AvoidMid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets.
But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
3 Unprofitable Stocks We’re Skeptical OfUnprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around.
Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.
3 Stocks Under $10 We Think Twice AboutStocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts.
But that doesn’t mean the underlying businesses are cheap, and we advise caution as many have questionable fundamentals.
1 Volatile Stock to Target This Week and 2 Facing HeadwindsVolatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
3 Stocks Under $50 with Open QuestionsThe $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead.
They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
1 Russell 2000 Stock to Research Further and 2 We Turn DownSmall-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
3 Russell 2000 Stocks We’re Skeptical OfThe Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential.
However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
3 Stocks Under $10 with Questionable Fundamentals Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums).
That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.
3 Reasons to Avoid BL and 1 Stock to Buy InsteadOver the past six months, BlackLine’s stock price fell to $56.82. Shareholders have lost 6% of their capital, which is disappointing considering the S&P 500 has climbed by 3.1%. This may have investors wondering how to approach the situation.
3 Reasons to Sell MTG and 1 Stock to Buy InsteadMGIC Investment has been treading water for the past six months, recording a small return of 3.8% while holding steady at $25.72.
Terex (TEX): Buy, Sell, or Hold Post Q1 Earnings?Since January 2025, Terex has been in a holding pattern, posting a small return of 2.7% while floating around $50.24.
Methode Electronics (MEI): Buy, Sell, or Hold Post Q1 Earnings?Methode Electronics has gotten torched over the last six months - since January 2025, its stock price has dropped 48.9% to $6.65 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
2 Reasons to Like CW (and 1 Not So Much)Curtiss-Wright currently trades at $474.48 and has been a dream stock for shareholders. It’s returned 416% since July 2020, blowing past the S&P 500’s 94.7% gain. The company has also beaten the index over the past six months as its stock price is up 23.5% thanks to its solid quarterly results.
3 Reasons ALGM is Risky and 1 Stock to Buy InsteadAllegro MicroSystems has been on fire lately. In the past six months alone, the company’s stock price has rocketed 40.4%, reaching $35.02 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Campbell's (CPB): Buy, Sell, or Hold Post Q1 Earnings?Over the past six months, Campbell’s stock price fell to $32.23. Shareholders have lost 16.5% of their capital, which is disappointing considering the S&P 500 has climbed by 3.1%. This may have investors wondering how to approach the situation.
3 Reasons to Sell EGHT and 1 Stock to Buy InsteadWhat a brutal six months it’s been for 8x8. The stock has dropped 27% and now trades at $2, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons to Avoid DVA and 1 Stock to Buy InsteadOver the past six months, DaVita’s shares (currently trading at $146.05) have posted a disappointing 14% loss, well below the S&P 500’s 3.1% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons We’re Fans of DoorDash (DASH)DoorDash’s 31.6% return over the past six months has outpaced the S&P 500 by 28.5%, and its stock price has climbed to $241 per share. This run-up might have investors contemplating their next move.
3 Reasons to Sell CTOS and 1 Stock to Buy InsteadCustom Truck One Source trades at $5.75 and has moved in lockstep with the market. Its shares have returned 7.1% over the last six months while the S&P 500 has gained 3.1%.
2 Reasons DOCN is Risky and 1 Stock to Buy InsteadShareholders of DigitalOcean would probably like to forget the past six months even happened. The stock dropped 25.7% and now trades at $28.78. This may have investors wondering how to approach the situation.
3 Reasons to Avoid HII and 1 Stock to Buy InsteadHuntington Ingalls has had an impressive run over the past six months as its shares have beaten the S&P 500 by 20.9%. The stock now trades at $253.23, marking a 24% gain. This performance may have investors wondering how to approach the situation.
3 Reasons to Avoid FWRG and 1 Stock to Buy InsteadOver the last six months, First Watch’s shares have sunk to $17.63, producing a disappointing 8.7% loss - a stark contrast to the S&P 500’s 3.1% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons to Avoid GH and 1 Stock to Buy InsteadOver the last six months, Guardant Health’s shares have sunk to $46.13, producing a disappointing 5.1% loss - a stark contrast to the S&P 500’s 3.1% gain. This may have investors wondering how to approach the situation.
Hillenbrand (HI): Buy, Sell, or Hold Post Q1 Earnings?What a brutal six months it’s been for Hillenbrand. The stock has dropped 35.9% and now trades at $22.66, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Gates Industrial Corporation (GTES): Buy, Sell, or Hold Post Q1 Earnings?Gates Industrial Corporation’s 17.9% return over the past six months has outpaced the S&P 500 by 14.7%, and its stock price has climbed to $24.49 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Sell SHOO and 1 Stock to Buy InsteadWhat a brutal six months it’s been for Steven Madden. The stock has dropped 35.1% and now trades at $27.25, rattling many shareholders. This may have investors wondering how to approach the situation.
3 Reasons to Sell BGS and 1 Stock to Buy InsteadB&G Foods has gotten torched over the last six months - since January 2025, its stock price has dropped 31.9% to $4.48 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons ALG is Risky and 1 Stock to Buy InsteadOver the past six months, Alamo has been a great trade, beating the S&P 500 by 14.4%. Its stock price has climbed to $216.45, representing a healthy 17.5% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons to Sell BBCP and 1 Stock to Buy InsteadConcrete Pumping has gotten torched over the last six months - since January 2025, its stock price has dropped 20.8% to $6.95 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons WYNN is Risky and 1 Stock to Buy InsteadWynn Resorts has had an impressive run over the past six months as its shares have beaten the S&P 500 by 23.5%. The stock now trades at $107.72, marking a 26.6% gain. This run-up might have investors contemplating their next move.
Zillow (ZG): Buy, Sell, or Hold Post Q1 Earnings?Zillow has been treading water for the past six months, recording a small return of 1.4% while holding steady at $77.87.
3 Reasons to Avoid ETSY and 1 Stock to Buy InsteadEtsy’s 19.9% return over the past six months has outpaced the S&P 500 by 16.8%, and its stock price has climbed to $63.65 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Avoid BTSG and 1 Stock to Buy InsteadOver the past six months, BrightSpring Health Services’s stock price fell to $20.33. Shareholders have lost 5.7% of their capital, which is disappointing considering the S&P 500 has climbed by 3.1%. This may have investors wondering how to approach the situation.
3 Reasons Investors Love Super Micro (SMCI)The past six months have been a windfall for Super Micro’s shareholders. The company’s stock price has jumped 49.9%, hitting $50.08 per share. This performance may have investors wondering how to approach the situation.
3 Reasons to Sell TFIN and 1 Stock to Buy InsteadShareholders of Triumph Financial would probably like to forget the past six months even happened. The stock dropped 20.7% and now trades at $62.56. This may have investors wondering how to approach the situation.
3 Reasons to Sell HGV and 1 Stock to Buy InsteadOver the past six months, Hilton Grand Vacations has been a great trade, beating the S&P 500 by 14.3%. Its stock price has climbed to $48.75, representing a healthy 17.5% increase. This run-up might have investors contemplating their next move.
3 Reasons to Sell NSSC and 1 Stock to Buy InsteadOver the past six months, Napco’s stock price fell to $30.32. Shareholders have lost 17.9% of their capital, which is disappointing considering the S&P 500 has climbed by 3.1%. This might have investors contemplating their next move.
3 Reasons to Sell LZB and 1 Stock to Buy InsteadOver the past six months, La-Z-Boy’s shares (currently trading at $38.26) have posted a disappointing 16% loss, well below the S&P 500’s 3.1% gain. This might have investors contemplating their next move.
3 Reasons to Avoid MX and 1 Stock to Buy InsteadMagnachip has been treading water for the past six months, recording a small return of 3.9% while holding steady at $4.25.
